When a measles outbreak took hold across two provinces of the Democratic Republic of Congo (DRC) in late 2005, it became one of the more closely documented tests of a strategy that was, at the time, still contested: reactive vaccination in a population where routine coverage was already above the textbook threshold for herd protection. The resulting measles outbreak case study, built from surveillance data and post-campaign coverage surveys in the cities of Matadi and Mbuji-Mayi, went on to inform how the World Health Organization framed reactive campaigns in its own measles mortality reduction guidance.
What Happened: Two Cities, Two Outbreaks
The outbreak did not move as a single national wave. In Matadi, in the west of the country, surveillance recorded 1,035 measles cases between 24 October 2005 and 19 February 2006. Further east, in Mbuji-Mayi, the outbreak was considerably larger: 4,734 cases were reported between 3 October 2005 and 30 April 2006. Both cities sat in a country where measles resurgence was, and remains, a recurring pattern rather than an anomaly — driven by gaps in routine immunization, uneven supplementary campaigns in prior years, and the disruption that population displacement and conflict routinely impose on district health services.
What made the two outbreaks a useful comparison rather than two isolated events was that both cities already reported baseline vaccination coverage above 70 percent — the rough figure long treated as adequate for outbreak suppression. That both still experienced substantial outbreaks was itself a finding worth sitting with before any intervention began.
Neither outbreak was an isolated accident of bad luck. The DRC has long recorded recurrent measles resurgence, and the drivers are consistent from one outbreak to the next: routine immunization coverage that falls short in practice even when national averages look adequate, supplementary campaigns in prior years that didn’t reach every district evenly, underreporting that makes the true case count larger than what surveillance captures, and conflict or displacement that periodically cuts districts off from health services altogether. None of that is unique to 2005-2006 — it is the backdrop against which any outbreak in the country has to be read, then and since.
The Reactive Vaccination Response
Médecins Sans Frontières (MSF) supported the Ministry of Health in both locations with a three-part response: mass reactive vaccination campaigns, free treatment for measles cases and complications, and reinforced case surveillance to track the outbreak’s trajectory in near real time. Reactive vaccination — launching a mass campaign after an outbreak is already under way, rather than waiting for the next scheduled supplementary immunization activity — was, at the time, not yet the settled default in outbreak response doctrine. Whether it was worth the operational cost in a setting with already-decent baseline coverage was an open question the campaigns in Matadi and Mbuji-Mayi were, in effect, answering in real time.
What the Numbers Showed
The post-campaign coverage surveys and continued surveillance produced a comparison that is unusually clean for two field campaigns run in different provinces under different logistical conditions:
| Metric | Matadi | Mbuji-Mayi |
|---|---|---|
| Cases reported (outbreak period) | 1,035 | 4,734 |
| Vaccination coverage before campaign | 87.5% | 74.0% |
| Vaccination coverage after campaign | 97.1% | 96.5% |
| Weekly case reduction within 3 weeks post-campaign | 89.3% | 68.9% |
The pattern that emerges is not simply "vaccination worked" — that would be true of nearly any measles campaign. It is that the size of the coverage gain and the speed of the case decline were both substantial even in Matadi, where pre-campaign coverage was already comfortably above 70 percent. The operational research conclusion drawn from the two sites was specific: reactive vaccination remained a feasible and effective outbreak-control tool even where baseline coverage would ordinarily be considered protective on paper.
Why This Case Study Still Matters
Retrospective analyses like this one earn their place in outbreak response literature not because the outcome was surprising in isolation, but because they replace intuition with a measured before-and-after. A field team weighing whether a reactive campaign is worth the logistics, the vaccine supply, and the disruption to routine services in an already-partially-vaccinated population has, in this case study, a concrete reference point rather than a guess. The finding that reactive vaccination held value above the 70 percent coverage line was one of the pieces of evidence that fed into the WHO’s subsequent guidance recommending reactive campaigns as a standard tool in measles mortality reduction settings, not only in settings with visibly poor baseline coverage.
The case study also underscores a harder, less flattering lesson: surveillance and post-campaign coverage surveys were what made the comparison possible at all. Without the case counts from Matadi and Mbuji-Mayi being tracked on a weekly basis, and without someone bothering to survey coverage before and after, the campaigns would have happened and ended with only an impression of success, not a measured one. That discipline — count before, count during, count after — is the part of this outbreak that is easiest to skip under field pressure and the part on which everything else in the analysis depends.
It is also worth being honest about what the case study does not settle. Two cities is not a national trial, and the campaigns took place inside a broader Ministry of Health and MSF response that also included free treatment and reinforced surveillance — interventions that likely contributed to the outcome alongside vaccination itself. A retrospective case study of this kind is a strong piece of evidence, not a controlled experiment, and reading it as the latter risks overstating how cleanly the case decline can be attributed to the vaccination campaign alone. That caveat doesn’t erase the finding; it simply belongs alongside it, the way any honest retrospective analysis of an outbreak response should carry its own limits into the record.
Conclusion
The DRC’s 2005-2006 measles outbreak, split across Matadi and Mbuji-Mayi, remains one of the more concrete examples in the field-epidemiology record of what a well-surveilled reactive vaccination campaign can show. Two cities, two case loads, two coverage baselines — and in both, a fast, measurable decline in transmission following the campaign. As a measles outbreak case study, its value is less in the headline percentages and more in what it demonstrates about pairing intervention with measurement: the campaigns worked, and because the surveillance was in place, that claim did not have to rest on impression alone.